(in millions $) | 14 Nov 2023 | 14 Aug 2023 | 30 Jul 2023 | 27 Apr 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $3956940.42 | $3824816.54 | $944 | $2171155.32 |
Short term investments | $615828.33 | $519684.57 | $309141.35 | |
Net receivables | $2356667.16 | $3571097.37 | $3634608 | $2829415.98 |
Inventory | $3241731.54 | $2662287.99 | $2681583 | $2981889 |
Total current assets | $10171167.45 | $10577886.47 | $10654550 | $9802251.26 |
Long term investments | $26169200.92 | $26525171.08 | $27237353.6 | |
Property, plant & equipment | $20284959.34 | $20686713.47 | $20836641 | $21741459.07 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $36340368.37 | $37103057.56 | $37371963 | $37039604.86 |
Current liabilities | ||||
Accounts payable | $2872472.12 | $2458709.43 | $4480948 | $3365934.67 |
Deferred revenue | ||||
Short long term debt | $5682472.91 | |||
Total current liabilities | $14095363.74 | $13106855.7 | $13201848 | $14491086.38 |
Long term debt | $11373783 | $12109960 | $12510792 | $9953116.52 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $29266831.39 | $29260740.97 | $29472809 | $26785278.85 |
Shareholders' equity | ||||
Retained earnings | $2485393.8 | $3263598.98 | $3287252 | $5563067.31 |
Other shareholder equity | $515976 | $699124 | $571710 | $781522 |
Total shareholder equity | $7073536.98 | $7842316.59 | $10254326.01 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $3 | $1076 | $3541597 | $4218099 |
Short term investments | $309141.35 | $743305 | $10496 | |
Net receivables | $3375583 | $2565316 | $4696688 | $4390046 |
Inventory | $2527728 | $2872918 | $3350375 | $2170656 |
Total current assets | $9503186 | $9444035 | $13187067 | $11099470 |
Long term investments | $27237353.6 | $126730 | $130310 | |
Property, plant & equipment | $20200332 | $20946933 | $20558446 | $20147051 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $19177.64 | |||
Total investments | ||||
Total assets | $35759298 | $35686019 | $38154515 | $35071523 |
Current liabilities | ||||
Accounts payable | $4175064 | $4061684 | $4814055 | $3779290 |
Deferred revenue | ||||
Short long term debt | $5682472.91 | $4069712 | $2764584 | |
Total current liabilities | $13885028 | $13961520 | $13994817 | $11006948 |
Long term debt | $11373783 | $9589387 | $8702745 | $11076949 |
Total noncurrent liabilities | $9062.11 | |||
Total debt | $13165.4 | |||
Total liabilities | $28527116 | $25806430 | $23392014 | $22334584 |
Shareholders' equity | ||||
Retained earnings | $2676014 | $5359769 | $8541521 | $7524297 |
Other shareholder equity | $515976 | $479628 | $537142 | -$163446 |
Total shareholder equity | $10254326.01 | $12997472 | $11401043 |
(in millions $) | 14 Nov 2023 | 14 Aug 2023 | 30 Jul 2023 | 27 Apr 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4632647.82 | $4704475.19 | $4738571 | $8308315.36 |
Cost of revenue | $4596508.56 | $4875855.1 | $8350365.09 | |
Gross Profit | $36139.26 | -$171379.92 | -$172622 | -$42049.73 |
Operating activities | ||||
Research & development | $335092.19 | $337509.89 | $445858.93 | |
Selling, general & administrative | $342008.31 | $366237.68 | $532154.07 | |
Total operating expenses | $5271475.36 | $5579968.03 | $708848 | $9328895.92 |
Operating income | -$638827.54 | -$875492.84 | -$1020580.57 | |
Income from continuing operations | ||||
EBIT | -$638380.27 | -$874816.74 | -$1017252.82 | |
Income tax expense | -$223692.64 | -$177076.63 | -$178360 | $199089.89 |
Interest expense | $101509 | |||
Net income | ||||
Net income | -$697058.9 | -$851950.47 | -$858124.9 | -$2080989.99 |
Income (for common shares) | -$697058.9 | -$851950.47 | -$2080989.99 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $21330819 | $26151781 | $29878043.07 | $24230124 |
Cost of revenue | $27647434.94 | $21587554 | ||
Gross Profit | $345176 | $1124078 | $2230608.13 | $2642570 |
Operating activities | ||||
Research & development | $1098736 | |||
Selling, general & administrative | $1572951 | |||
Total operating expenses | $2855340 | $3209125 | $27647434.94 | $24259241 |
Operating income | $2230608.13 | -$29117 | ||
Income from continuing operations | ||||
EBIT | $2230608.13 | -$29117 | ||
Income tax expense | -$762712 | -$237785 | $385340.4 | -$524462 |
Interest expense | -$570065 | $93153 | -$370479 | |
Net income | ||||
Net income | -$2733741.84 | -$3071564.67 | $1333544.16 | -$89342 |
Income (for common shares) | $1333544.16 | -$89342 |
(in millions $) | 14 Nov 2023 | 14 Aug 2023 | 30 Jul 2023 | 27 Apr 2023 |
---|---|---|---|---|
Net income | -$697058.9 | -$851950.47 | -$2080989.99 | |
Operating activities | ||||
Depreciation | $1905363.15 | $40614.68 | $1558341.79 | |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $4018674.14 | -$1662273.5 | $970701.73 | |
Investing activities | ||||
Capital expenditures | -$1497019.7 | -$197975.97 | -$2109926.63 | |
Investments | ||||
Total cash flows from investing | -$2649072.64 | $1611456.99 | -$1783849 | -$2183345.11 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | -$4572768.75 | -$4344501.11 | $13155292.76 | |
Total cash flows from financing | $598631.61 | -$501496.7 | $2178267 | $968381.75 |
Effect of exchange rate | -$27903 | |||
Change in cash and equivalents | $3956940.42 | $3824816.54 | $553790 | $2171155.32 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
---|---|---|---|---|
Net income | $1333544.16 | -$89342 | ||
Operating activities | ||||
Depreciation | $3769578 | |||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $2286948 | |||
Investing activities | ||||
Capital expenditures | -$2603545 | |||
Investments | -$617 | |||
Total cash flows from investing | -$2589336 | -$6700169 | -$2319316 | |
Financing activities | ||||
Dividends paid | -$232580 | |||
Sale and purchase of stock | ||||
Net borrowings | $770949 | |||
Total cash flows from financing | $1350863 | $1946024 | $931829 | |
Effect of exchange rate | -$11402 | $26177 | -$17365 | |
Change in cash and equivalents | $432873 | -$1716948 | $882096 |
Market cap | $3.81B |
---|---|
Enterprise value | N/A |
Shares outstanding | 1.00B |
Revenue | $22.38T |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | -$4.49T |
Revenue Q/Q | -36.55% |
Revenue Y/Y | N/A |
P/E ratio | -0.00 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 0.00 |
P/B ratio | 0.00 |
Book/Share | 6.56K |
Cash/Share | 3.96K |
EPS | -$4.49K |
---|---|
ROA | -12.14% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.72 |
Quick ratio | 0.49 |